Study of ropivacaine, sodium chloride and gadoteric acid in nerve blocks for hip pain in healthy volunteers

2 1 1

What is this study about?

This study focuses on investigating nerve blocks for hip pain management. The research compares two different types of nerve blocks: the subpectineal obturator nerve blockade (SOB) and suprainguinal fascia iliaca compartment block (SIFICB). These procedures involve injecting medications near specific nerves to provide pain relief in the hip area.

The medications used in this study include Ropivacaine, which is a local anesthetic solution for injection, and Dotarem, a contrast agent used for imaging. Sodium chloride solution is also used during the procedure. The purpose of the study is to determine how effectively these nerve blocks can reduce sensation in specific nerves, particularly the obturator nerve.

During the study, participants will receive nerve blocks and undergo various tests to measure the effectiveness of the treatment. These tests include muscle strength measurements and special imaging called MRI to see how the medication spreads in the body. The study will evaluate how well the nerve blocks work by measuring changes in muscle activity and areas of numbness in the skin.

1 Initial nerve block procedure

You will receive one of two types of nerve blocks: either a suprainguinal fascia iliaca compartment block (SIFICB) or a subpectineal obturator nerve blockade (SOB)

The procedure involves an injection of Ropivacain (local anesthetic) and sodium chloride solution in the hip area

The injection will be administered through the skin to target specific nerve areas

2 Muscle response testing

Your muscle responses will be measured using EMG (a test that records electrical signals from muscles)

The test focuses on the gracilis muscle (inner thigh muscle)

Measurements will be taken before and after the nerve block to compare the differences

3 Imaging procedure

You will undergo an MRI scan using Dotarem (contrast agent)

The imaging will show how the medication spreads in the targeted area

This procedure helps to verify the placement and distribution of the nerve block

4 Strength assessment

Your muscle strength will be measured using a special device called a dynamometer

The test will focus on your thigh muscles (adductor and quadriceps)

The measurements will help determine how the nerve block affects muscle function

5 Skin sensation testing

Your skin sensation will be tested in the affected area

The test will determine where the numbness occurs

The size of the numb area will be measured and documented

Who Can Join the Study?

  • Patient must be 18 years or older
  • Patient must have a BMI (Body Mass Index) less than 25 kg/m² – BMI is a measure that uses your height and weight to determine if your weight is healthy
  • Patient must weigh 69 kilograms or more
  • Patient must be classified as ASA I or II – this means being healthy or having only mild systemic disease according to the American Society of Anesthesiologists classification system
  • Patient must be able to read and understand Danish
  • Patient must be able to read, understand and sign the informed consent form
  • Both male and female participants can join the study

Who Cannot Join the Study?

  • Body Mass Index (BMI) over 35 (severe obesity)
  • Known allergies to local anesthetic medications
  • History of blood clotting disorders or current use of blood thinners
  • Active infection in the hip or groin area
  • Previous surgery in the hip region
  • Neurological conditions affecting the hip or leg
  • Pregnancy or breastfeeding
  • Inability to provide informed consent
  • Current participation in other clinical trials
  • Chronic pain conditions requiring regular pain medication
  • Uncontrolled high blood pressure
  • Severe heart, liver, or kidney disease
  • History of adverse reactions to medical procedures
  • Mental health conditions that could affect study participation
  • Use of medications that could interact with the study procedures

Where you can join this trial?

Verified and Recommended Sites

No sites found in this category

Verified Sites

No sites found in this category

Other Sites

Site Name City Country Status
Region Midtjylland Aarhus Denmark

Want to learn more about this study or check if you can participate? Contact us.

Trial status

Country Status Recruitment Start
Denmark Denmark
Not yet recruiting
01.03.2024

Trial locations

Suprainguinal fascia iliaca compartment block (SIFICB) is a type of local anesthetic nerve block technique where medication is injected into a specific anatomical space above the groin area. This technique aims to provide pain relief by blocking several nerves that supply sensation to the hip and thigh region.

Subpectineal obturator nerve block (SOB) is another type of local anesthetic nerve block that specifically targets the obturator nerve, which provides sensation to parts of the thigh and hip joint. The medication is injected near the obturator nerve as it passes through the pectineal muscle.

Note: While the specific local anesthetic medication used in these nerve blocks is not mentioned in the source data, these procedures typically use local anesthetic medications to temporarily block nerve signals in the targeted areas.

Investigated diseases:

Hip Pain – A condition characterized by discomfort, aching, or soreness in or around the hip joint. The pain can develop gradually or suddenly, affecting the ability to walk, climb stairs, or perform daily activities. Hip pain may be felt in various areas around the hip joint, including the thigh, groin, or buttocks. The condition can range from mild to severe and may be accompanied by stiffness, reduced range of motion, or weakness in the affected area. Hip pain can affect people of all ages and may result from various underlying causes.

Trial ID:
2023-510388-37-00
Protocol code:
SIFICB
Trial Phase:
Therapeutic exploratory (Phase II)

Other Trials to Consider

  • Study on Managing Moderate to Severe Limb Trauma Pain in Emergency Patients Using Sublingual Sufentanil Compared to a Drug Combination

    Recruiting

    3 1 1 1
    France